ArticleHaematologica2019
Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the
Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a practical guide to diagnosis and management.Leukemia · 2025Review
- Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations.Haematologica · 2025Review
- [Unusual progression of polycythemia vera].Innere Medizin (Heidelberg, Germany) · 2024Article
- Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.American journal of hematology · 2024Review
- Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.Blood advances · 2022Article
- How I diagnose and treat chronic myelomonocytic leukemia.Haematologica · 2022Article
- Mutations in chronic myelomonocytic leukemia and their prognostic relevance.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021Review
- RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.Nature communications · 2021Article
- Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Hematology. American Society of Hematology. Education Program · 2020Review
- Article
- Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.Current hematologic malignancy reports · 2019Review
- Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.Current oncology reports · 2019Review
- Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.Haematologica · 2019Review
- The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.Wiener klinische Wochenschrift · 2019Article
- Role of JAK2 V617F in Myeloproliferative Neoplasms: From Mutation to Manifestation: A Review.Nigerian medical journal : journal of the Nigeria Medical AssociationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.